2020-07-16 13:36:29 | Principia jumps after Bloomberg says Sanofi exploring potential buyoutSanofi (SNY) is studying potential acquisitions of U.S. biotechnology companies including Principia Biopharma (PRNB) in an effort to obtain treatments for clinical areas such as multiple sclerosis and immune disorders, Bloomberg reports, citing people with knowledge of the matter said. Sanofi is working with advisers to study potential deals, sources told Bloomberg. The company already has a partnership with Principia, whose stock halted for volatility after jumping well off the day's lows following the report. It halted down 3% to $72.14. | |
---|